Scaling Regenerative Medicine Production With PolarityBio’s Nikolai Sopko, MD, Ph.D.

In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Nikolai Sopko, MD, Ph.D., chief operating officer, chief scientific officer, and director at PolarityBio, a biotech company developing SkinTE, an investigational autologous regenerative skin therapy for diabetic foot ulcers. The two discuss the challenges of scaling autologous therapy manufacturing, as well as the success PolarityBio has found in doing so through its parallel processing approach.

Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/

Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/

Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions

Tell us how we can improve. Take our 60-second survey: https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header